Quantum unveiled for the Asian market at CPhi China
Presspart Manufacturing has unveiled their latest product innovation, the Quantum Dose Indicator System, to the Asian market at this year’s CPhi China.
Presspart, the world’s leading manufacturer of respiratory drug delivery components, exhibited at CPhi China along with over 2,500 companies from within the pharmaceutical supply chain. Over 3 days over 30,000 attendees visited the show making CPhi China the biggest pharmaceutical show in China.
During the show Presspart showcased its latest product innovation, the Quantum dose indication system for metered-dose inhalers. The Quantum end of life indicator has been developed to be a low cost, disposable dose indicator solution, ensuring patients don’t run out of their medication when they need it the most.
Presspart also gave visitors the chance to see their full range of metered-dose inhaler components, including MDI cans and MDI actuators, Presspart’s full range of healthcare dispensing actuators, as well as introducing visitors to Presspart’s recently introduced Inhalation Product Technology Centre.
During CPhi Leo Shi, Presspart’s Asia-Pacific Sales Manger, gave a 30 minute speech on ” “innovations in respiratory device development – now, tomorrow and on the horizon “, discussing how respiratory drug delivery devices are developing and what we can expect from the future, with particular emphasis on dose counters and dose indicators.
Leo Shi, Presspart’s Asia-Pacific Sales Manager commented “Presspart attended CPhi China last year and it is a very worthwhile show. It is the only opportunity to get the full pharmaceutical supply chain under one roof in the China market. It was also a great opportunity to show visitors our new Quantum dose indication system and it was very well received”.
For more information on Presspart’s product range please contact Presspart